NeuroVoices: Brian Lin, PhD, on the FDA Approval of Gefurulimab for Generalized Myasthenia Gravis

Author profile image Aggregator
0 comments
The senior director of research at the Muscular Dystrophy Association discussed what the newly approved once-weekly C5 inhibitor adds to generalized myasthenia gravis care.

Source: NeurologyLive Published 18 Nov 2026 Imported 18 Nov 2026 Relevancy: Not reviewed

Read the article